Last reviewed · How we verify
NCT06079892: RFH
Hemorrhoid Radiofrequency
trial testing radiofrequency in Hemorrhoid Prolapse in 80 participants. Status unknown.
1 October 2024
Quick facts
| Lead sponsor | Fondation Hôpital Saint-Joseph |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 1 March 2017 |
| Primary completion | 1 October 2024 |
| Estimated completion | 1 January 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- radiofrequency — full drug profile →
Conditions studied
- Hemorrhoid Prolapse — all drugs for Hemorrhoid Prolapse →
Sponsor
Fondation Hôpital Saint-Joseph — full company profile →
Who can join
18 and older, any sex, with Hemorrhoid Prolapse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Triapedicular haemorroidectomy is currently the gold standard in haemorrhoidal pathology. Minimally invasive surgical techniques now play an important role in the haemorrhoidal management algorithm, particularly for less advanced stages of the disease. Among these techniques, radiofrequency is one of the most recent and is gradually gaining ground. It involves applying a radiofrequency current to the internal haemorrhoidal tissue in order to induce its involution. The literature has shown that this technique leads to symptomatic improvement in over 60% of cases and a high satisfaction rate, even though some patients still seem to have haemorrhoidal symptoms postoperatively. The aim of this study is to evaluate the efficacy of this technique in patients with haemorrhoidal pathology operated on at our centre, using "hard" criteria which are thought to be more rigorous ("cure" rather than "improvement").
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Latest Research Trends on the Management of Hemorrhoids.
Kang SI. · · 2025 · cited 3× · PMID 40302863 · DOI 10.23922/jarc.2024-090
Verify or expand the search:
- PubMed search for NCT06079892
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of radiofrequency
Trials testing the same drug.
- NCT06678061 — Radiofrequency Splanchnic Denervation ,Neurolytic Retrocrural Celiac Plexus Block Chronic Upper Abdominal Cancer Pain · NA · completed
- NCT05096520 — Intermedius Genicular Nerve in the Treatment of Patients With Chondromalacia Patella · NA · unknown
- NCT05185193 — Efficacy and Safety Evaluation of Changes in Lower Extremity Edema of Radiofrequency · NA · completed
- NCT04413526 — Radiofrequency-assisted Liver Resection in Intractable Liver Cancer · completed
- NCT03886142 — Platelet Rich Plasma Versus Radio Frequency for Chronic Knee Arthritis · NA · completed
Other Fondation Hôpital Saint-Joseph trials
Trials by the same sponsor.
- NCT07512960 — Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal Revascularization · Phase 3 · not yet recruiting
- NCT07512908 — Study of Factors Influencing the Dynamics of Colonisation and Decolonisation of the Digestive Tract by Clostridioides Di · NA · not yet recruiting
- NCT07512830 — Evaluation of the Benefits of Hypnosis During Transoesophageal Echocardiography · NA · recruiting
- NCT07348081 — Real World Evidence to Assess the Value of a Digital Care Coordination and Monitoring Program for Supporting Caregivers · NA · recruiting
- NCT07086612 — Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) and Transverse Orthodontic Deficiency in Children · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06079892 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fondation Hôpital Saint-Joseph
- Last refreshed: 12 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06079892.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing